Loading
Yanuki
KEYWORD TOPIC
Investor Concerns Grow Over Oracle's AI Cloud Push | Investor Concerns Over Oracle's OpenAI Deal | Blue Owl Calls Off Private Credit Fund Merger After Investor Concerns | Obesity Drug Market Hits Turning Point Amidst Investor Concerns | X (Formerly Twitter) Faces Operational Instability and Investor Concerns After Outage | TransUnion's Financial Performance: Slowing Returns Raise Investor Questions | Investor Concerns Grow Over Oracle's AI Cloud Push | Investor Concerns Over Oracle's OpenAI Deal | Blue Owl Calls Off Private Credit Fund Merger After Investor Concerns | Obesity Drug Market Hits Turning Point Amidst Investor Concerns | X (Formerly Twitter) Faces Operational Instability and Investor Concerns After Outage | TransUnion's Financial Performance: Slowing Returns Raise Investor Questions

Markets / Investing

Investor Concerns Grow Over Oracle's AI Cloud Push

Oracle's aggressive pivot towards becoming an AI cloud-computing leader is facing increased scrutiny from investors. The company's significant financial commitments to this transformation, particularly its reliance on OpenAI, have sparked c...

Should Investors Be Concerned About Oracle?
Investor Concerns Grow Over Oracle's AI Cloud Push Image via The Wall Street Journal
TOPIC investor concerns

Markets / Investing

Investor Concerns Over Oracle's OpenAI Deal

Investors are showing increasing apprehension regarding Oracle's substantial $300 billion deal with OpenAI, leading to a notable decrease in Oracle's market value. This unease stems from concerns about Oracle's debt-financed expansion into...

Should Investors Be Concerned About Oracle?

Finance / Private Credit

Blue Owl Calls Off Private Credit Fund Merger After Investor Concerns

Blue Owl has decided to call off the merging of two of its private-credit funds after the deal caused some angst among investors, according to people familiar with the matter. The firm had planned to merge its smaller, non-traded Blue Owl C...

Blue Owl calls off merger of its two private-credit funds after announcement rattles stock, sources say

Health / Weight Loss

Obesity Drug Market Hits Turning Point Amidst Investor Concerns

The once-promising obesity drug market faces a turning point as investor enthusiasm cools amidst concerns over lackluster results, potential copycat drugs, and pricing pressures. Pharmaceutical giants Novo Nordisk and Eli Lilly are now unde...

Obesity drug market hits turning point after lackluster results and lull in startups